Genetic Technologies Ltd has released a press release.
Publication Highlights geneType Outperforms Current Models
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- Business Update - February 2023
- Supplementary Announcement - Comprehensive Risk Test
- Genetic Technologies Announces US$5M Registered Direct Offer
- World First Comprehensive Risk Test-Breast & Ovarian Cancer
- GTG to form Strategic Alliance with global leader QIAGEN
Later from Genetic Technologies
- Receipt of R&D Tax Incentive Refund for geneType Multi Test
- Appendix 4D & Half-year Financial Report December 2022
- Further Study Validates geneType Breast Cancer Risk Test
- GeneType MultiTest Panel Expanded Inclusion of New Diseases
- Publication Validates geneType Prostate Cancer Risk Test
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies